Sussman Joel F. 4
4 · Galera Therapeutics, Inc. · Filed May 5, 2025
Insider Transaction Report
Form 4
Sussman Joel F.
Chief Accounting Officer
Transactions
- Award
Stock Option (Right to Buy)
2025-05-01+2,000,000→ 2,000,000 totalExercise: $0.02Exp: 2035-04-30→ Common Stock (2,000,000 underlying)
Footnotes (1)
- [F1]The option vests and becomes exercisable in 48 substantially equal monthly installments with the first installment vesting on June 1, 2025.